This is great news, fantastic.
Besides those results we can now be reassured that LC & Co. have hinted the truth. And that will be the case for all CF33 applications too.
A CR will come, no doubt. Qs is, will it be Bell Potter & Co at a huge discount or will Hopper finally sell the awesomeness of Azer-Cel and demand a price that reflects the data. Better would be a big pharma taking a big stake, that would shut up all Masons & Co.
GLTA
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial, page-99
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $368.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.8¢ | $373.9K | 7.653M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 2093718 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 5182633 | 36 |
View Market Depth
| Last trade - 14.47pm 07/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |